Perioperative fluid management for adult cardiac surgery: network meta-analysis pooling on twenty randomised controlled trials.

IF 2 3区 医学 Q2 ANESTHESIOLOGY
Yu-Tong Ma, Chen-Yang Xian-Yu, Yun-Xiang Yu, Chao Zhang
{"title":"Perioperative fluid management for adult cardiac surgery: network meta-analysis pooling on twenty randomised controlled trials.","authors":"Yu-Tong Ma, Chen-Yang Xian-Yu, Yun-Xiang Yu, Chao Zhang","doi":"10.1186/s13741-024-00440-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to evaluate colloids and crystalloids used in perioperative fluid therapy for cardiac surgery patients to further investigate the optimal management strategies of different solutions.</p><p><strong>Method: </strong>RCTs about adult surgical patients allocated to receive perioperative fluid therapy for electronic databases, including Ovid MEDLINE, EMBase, and Cochrane Central Register of Controlled Trials, were searched up to February 15, 2023.</p><p><strong>Results: </strong>None of the results based on network comparisons, including mortality, transfuse PLA, postoperative chest tube output over the first 24 h following surgery, and length of hospital stay, were statistically significant. Due to the small number of included studies, the results, including acute kidney injury, serum creatinine, serum microglobulin, and blood urea nitrogen, are from the direct comparison. For transfusion of RBCs, significant differences were observed in the comparisons of 3% gelatine vs. 6% HES 200/0.5, 4% albumin vs. 5% albumin, 4% gelatine vs. 5% albumin, 5% albumin vs. 6% HES 200/0.5, and 6% HES 130/0.4 vs. 6% HES 200/0.5. In transfusion of FFP, significant differences were observed in comparisons of 3% gelatine vs. 4% gelatine, 3% gelatine vs. 6% HES 200/0.5, 5% albumin vs. 6% HES 200/0.5, 4% gelatine vs. 5% albumin, 4% gelatine vs. 6% HES 200/0.4, and 6% HES 130/0.4 vs. 6% HES 200/0.5. For urinary output at 24 h after surgery, the results are deposited in the main text.</p><p><strong>Conclusion: </strong>This study showed that 3% gelatin and 5% albumin can reduce the transfuse RBC and FFP. In addition, the use of hypertonic saline solution can increase urine output, and 5% albumin and 6% HES can shorten the length of ICU stay. However, none of the perioperative fluids showed an objective advantage in various outcomes, including mortality, transfuse PLA, postoperative chest tube output over the first 24 h following surgery, and length of hospital stay. The reliable and sufficient evidences on the injury of the kidney, including acute kidney injury, serum creatinine, serum microglobulin, and blood urea nitrogen, was still lacking. In general, perioperative fluids had advantages and disadvantages, and there were no evidences to support the recommendation of the optimal perioperative fluid for cardiac surgery.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"13 1","pages":"76"},"PeriodicalIF":2.0000,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264963/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perioperative Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13741-024-00440-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The aim of this study was to evaluate colloids and crystalloids used in perioperative fluid therapy for cardiac surgery patients to further investigate the optimal management strategies of different solutions.

Method: RCTs about adult surgical patients allocated to receive perioperative fluid therapy for electronic databases, including Ovid MEDLINE, EMBase, and Cochrane Central Register of Controlled Trials, were searched up to February 15, 2023.

Results: None of the results based on network comparisons, including mortality, transfuse PLA, postoperative chest tube output over the first 24 h following surgery, and length of hospital stay, were statistically significant. Due to the small number of included studies, the results, including acute kidney injury, serum creatinine, serum microglobulin, and blood urea nitrogen, are from the direct comparison. For transfusion of RBCs, significant differences were observed in the comparisons of 3% gelatine vs. 6% HES 200/0.5, 4% albumin vs. 5% albumin, 4% gelatine vs. 5% albumin, 5% albumin vs. 6% HES 200/0.5, and 6% HES 130/0.4 vs. 6% HES 200/0.5. In transfusion of FFP, significant differences were observed in comparisons of 3% gelatine vs. 4% gelatine, 3% gelatine vs. 6% HES 200/0.5, 5% albumin vs. 6% HES 200/0.5, 4% gelatine vs. 5% albumin, 4% gelatine vs. 6% HES 200/0.4, and 6% HES 130/0.4 vs. 6% HES 200/0.5. For urinary output at 24 h after surgery, the results are deposited in the main text.

Conclusion: This study showed that 3% gelatin and 5% albumin can reduce the transfuse RBC and FFP. In addition, the use of hypertonic saline solution can increase urine output, and 5% albumin and 6% HES can shorten the length of ICU stay. However, none of the perioperative fluids showed an objective advantage in various outcomes, including mortality, transfuse PLA, postoperative chest tube output over the first 24 h following surgery, and length of hospital stay. The reliable and sufficient evidences on the injury of the kidney, including acute kidney injury, serum creatinine, serum microglobulin, and blood urea nitrogen, was still lacking. In general, perioperative fluids had advantages and disadvantages, and there were no evidences to support the recommendation of the optimal perioperative fluid for cardiac surgery.

成人心脏手术围手术期液体管理:汇集二十项随机对照试验的网络荟萃分析。
背景:本研究旨在评估心脏手术患者围手术期液体治疗中使用的胶体和晶体液:本研究旨在对心脏手术患者围手术期液体治疗中使用的胶体和晶体液进行评估,以进一步研究不同溶液的最佳管理策略:方法:检索了截至2023年2月15日的电子数据库(包括Ovid MEDLINE、EMBase和Cochrane Central Register of Controlled Trials)中关于分配给接受围手术期液体治疗的成人手术患者的RCT:结果:根据网络比较得出的结果,包括死亡率、输血量、术后 24 小时内胸管排液量和住院时间,均无统计学意义。由于纳入的研究较少,包括急性肾损伤、血清肌酐、血清微球蛋白和血尿素氮在内的结果均来自直接比较。在输注红细胞方面,3%明胶与 6% HES 200/0.5、4%白蛋白与 5%白蛋白、4%明胶与 5%白蛋白、5%白蛋白与 6% HES 200/0.5、6% HES 130/0.4 与 6% HES 200/0.5 的比较结果均有显著差异。在输注全蛋白纤维素方面,3%明胶与4%明胶、3%明胶与6% HES 200/0.5、5%白蛋白与6% HES 200/0.5、4%明胶与5%白蛋白、4%明胶与6% HES 200/0.4、6% HES 130/0.4与6% HES 200/0.5的比较均有显著差异。术后24小时的尿量结果见正文:本研究表明,3%明胶和5%白蛋白可减少RBC和FFP的输注。此外,使用高渗盐水可以增加尿量,5% 的白蛋白和 6% 的 HES 可以缩短重症监护室的住院时间。然而,没有一种围手术期液体在各种结果上显示出客观优势,包括死亡率、输血量、术后胸管在术后 24 小时内的排出量和住院时间。关于肾脏损伤,包括急性肾损伤、血清肌酐、血清微球蛋白和血尿素氮,仍缺乏可靠而充分的证据。总的来说,围手术期输液有利有弊,目前还没有证据支持心脏手术最佳围手术期输液的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
3.80%
发文量
55
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信